Katja Kollewe

649 total citations
15 papers, 468 citations indexed

About

Katja Kollewe is a scholar working on Neurology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Katja Kollewe has authored 15 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Physiology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Katja Kollewe's work include Botulinum Toxin and Related Neurological Disorders (12 papers), Neurological disorders and treatments (6 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Katja Kollewe is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (12 papers), Neurological disorders and treatments (6 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Katja Kollewe collaborates with scholars based in Germany and Iran. Katja Kollewe's co-authors include Dirk Dressler, Reinhard Dengler, Bahram Mohammadi, Lejla Paracka, Klaus Krampfl, Bahram Mohammadi, Nicole de Buhr, Hans Bigalke, Christoph Schrader and Fereshte Adib Saberi and has published in prestigious journals such as Journal of Neural Transmission, Parkinsonism & Related Disorders and Pain Medicine.

In The Last Decade

Katja Kollewe

14 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katja Kollewe Germany	12	365	131	127	107	100	15	468
Kevin D. Cairns United States	11	112 0.3×	63 0.5×	37 0.3×	65 0.6×	89 0.9×	17	380
S. Zeme Italy	13	260 0.7×	73 0.6×	147 1.2×	77 0.7×	88 0.9×	22	621
A Joffroy Belgium	12	154 0.4×	116 0.9×	58 0.5×	82 0.8×	64 0.6×	19	355
Masahiko Kasai Japan	13	358 1.0×	87 0.7×	31 0.2×	24 0.2×	136 1.4×	21	521
Ioannis G. Panourias Greece	14	231 0.6×	28 0.2×	36 0.3×	40 0.4×	78 0.8×	32	421
Katarzyna Trok Sweden	9	63 0.2×	138 1.1×	33 0.3×	212 2.0×	101 1.0×	14	390
G. Salar Italy	11	202 0.6×	124 0.9×	49 0.4×	74 0.7×	76 0.8×	31	409
M. Gabriele Italy	7	129 0.4×	102 0.8×	21 0.2×	74 0.7×	31 0.3×	10	378
Peter Zsigmond Sweden	16	267 0.7×	38 0.3×	32 0.3×	162 1.5×	130 1.3×	55	604
Simona Buscone Italy	10	201 0.6×	82 0.6×	70 0.6×	26 0.2×	38 0.4×	11	348

Countries citing papers authored by Katja Kollewe

Since Specialization

Citations

This map shows the geographic impact of Katja Kollewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Kollewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Kollewe more than expected).

Fields of papers citing papers by Katja Kollewe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Kollewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Kollewe. The network helps show where Katja Kollewe may publish in the future.

Co-authorship network of co-authors of Katja Kollewe

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Kollewe. A scholar is included among the top collaborators of Katja Kollewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Kollewe. Katja Kollewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kollewe, Katja, et al.. (2021). Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study. The Journal of Headache and Pain. 22(1). 50–50. 12 indexed citations

Kutschenko, Anna, Martin Klietz, Lejla Paracka, et al.. (2020). Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study. Journal of Neural Transmission. 127(8). 1161–1165. 11 indexed citations

Paracka, Lejla, et al.. (2016). Botulinum toxin in the management of chronic migraine: clinical evidence and experience. Therapeutic Advances in Neurological Disorders. 10(2). 127–135. 65 indexed citations

Kollewe, Katja, Dirk U. Wulff, Davood Fathi, et al.. (2016). Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting. Journal of Neural Transmission. 123(5). 533–540. 46 indexed citations

Paracka, Lejla, Katja Kollewe, Reinhard Dengler, & Dirk Dressler. (2015). Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures. Journal of Neural Transmission. 122(9). 1279–1282. 11 indexed citations

Kollewe, Katja, et al.. (2014). Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. Journal of Neural Transmission. 122(3). 427–431. 49 indexed citations

Dressler, Dirk, Fereshte Adib Saberi, Katja Kollewe, & Christoph Schrader. (2014). Safety aspects of incobotulinumtoxinA high-dose therapy. Journal of Neural Transmission. 122(2). 327–333. 41 indexed citations

Körner, Sonja, et al.. (2012). Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(1). 20–25. 53 indexed citations

Kollewe, Katja, Bahram Mohammadi, Reinhard Dengler, & Dirk Dressler. (2010). Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox® or Dysport®. Journal of Neural Transmission. 117(6). 759–763. 36 indexed citations

10.

Kollewe, Katja, TF Münte, Ali Samii, Reinhard Dengler, & Bahram Mohammadi. (2010). Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Klinische Neurophysiologie. 41(1). 2 indexed citations

11.

Kollewe, Katja, Lingjing Jin, Klaus Krampfl, Reinhard Dengler, & Bahram Mohammadi. (2009). Treatment of Phantom Limb Pain with Botulinum Toxin Type A: Table 1. Pain Medicine. 10(2). 300–303. 43 indexed citations

12.

Mohammadi, Bahram, et al.. (2009). A long-term follow-up of botulinum toxin A in cervical dystonia. Neurological Research. 31(5). 463–466. 67 indexed citations

13.

Mohammadi, Bahram, et al.. (2009). Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients. Neurological Research. 32(3). 309–313. 31 indexed citations

14.

Kollewe, Katja, Nicole de Buhr, K Krampfl, Reinhard Dengler, & Bahram Mohammadi. (2007). 1.254 Long-term follow-up of cervical dystonia patients treated with Botulinum toxin A. Parkinsonism & Related Disorders. 13. S66–S66. 1 indexed citations

15.

Mohammadi, Bahram, Katja Kollewe, Nicole de Buhr, et al.. (2007). Botulinum toxin A for the treatment of cervical dystonia. Klinische Neurophysiologie. 38(4).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact